Conference PaperPDF Available

Automated QT interval measurement in Holter ECGs recorded at 180 and 1000 samples/second

Authors:

Abstract and Figures

To study the effect of sampling rate on automated QT measurements, Holter ECGs were recorded at 180 and 1000 samples/second (s/s) using 2 recorders; 30 ECG snapshots were extracted at varying heart rates from 16 healthy subjects and re-sampled to 180, 500 or 1000s/s using the Antares software. QT interval by CalECG algorithm was longer (5.0±6.3 ms, p<;0.001) in 180s/s ECGs than in 1000s/s ECGs. It decreased to 2.1±5.8ms when 180s/s ECGs were re-sampled to 500s/s, and to 2.6±6.2ms at 1000s/s. It also decreased progressively on resampling both sets of ECGs to 1000s/s (2.6±6.2ms), 500s/s (1.8±5.5ms) and 180s/s (0.4±5.9ms). Differences in QT interval were independent of the QT measurement algorithm used: University of Glasgow (Uni-G) program and CalECG for 500s/s ECGs; Veritas and CalECG for 1000s/s ECGs. Thus, QT interval is longer in ECGs with lower sampling rates; resampling them to a higher resolution partially compensates for this.
Content may be subject to copyright.
Automated QT Interval Measurement in Holter ECGs Recorded at 180 and 1000
samples/second
GK Panicker
1
, V Salvi
1
, DR Karnad
1
, P Macfarlane
2
, E Clark
2
, A Ramasamy
1
, S Kothari
1
, D Narula
1
1
Quintiles Cardiac Safety Services, Mumbai, India
2
University of Glasgow, Glasgow, UK
Abstract
To study the effect of sampling rate on automated QT
measurements, Holter ECGs were recorded at 180 and
1000 samples/second (s/s) using 2 recorders; 30 ECG
snapshots were extracted at varying heart rates from 16
healthy subjects and re-sampled to 180, 500 or 1000s/s
using the Antares software. QT interval by CalECG
algorithm was longer (5.0±6.3 ms, p<0.001) in 180s/s
ECGs than in 1000s/s ECGs. It decreased to 2.1±5.8ms
when 180s/s ECGs were re-sampled to 500s/s, and to
2.6±6.2ms at 1000s/s. It also decreased progressively on
resampling both sets of ECGs to 1000s/s (2.6±6.2ms),
500s/s (1.8±5.5ms) and 180s/s (0.4±5.9ms). Differences
in QT interval were independent of the QT measurement
algorithm used: University of Glasgow (Uni-G) program
and CalECG for 500s/s ECGs; Veritas and CalECG for
1000s/s ECGs. Thus, QT interval is longer in ECGs with
lower sampling rates; resampling them to a higher
resolution partially compensates for this.
1. Introduction
Digital 12-lead resting ECGs are used in clinical
research or drug trials for studying changes in various
intervals in the ECG. Regulatory guidelines require that
studies designed to detect QTc prolongation by a new
drug are able to detect a mean prolongation of 5
milliseconds (ms).
1
Electrocardiographs with a sampling
rate of 500 or 1000 s/s are used for this purpose.
Improvements in acquisition and storage technology have
permitted recording of longer durations of continuous 12-
lead Holter ECG recordings at sampling rates of up to
1000 samples per second (s/s). However, due to cost
constraints, 12-lead Holters with lower sampling rates are
still used in many studies.
Holter ECGs recorded at 180 s/s have data points that
are 5.6 ms apart. Is the QT interval in these ECGs
comparable with that in Holter ECGs recorded at 1000
s/s where data points are 1 ms apart? This question is
more pertinent when a computer algorithm is used for
measurement of various intervals as automated QT
measurement algorithms place annotations on sample
points and not between them. Moreover, many computer
programs can only analyze ECGs at a specified sampling
rate. Consequently, digital 12-lead Holter recordings
acquired at lower sampling rates are often up-sampled to
a higher sampling rate, before further analysis. This
involves interpolation of data values between actual
samples. How up-sampling affects automated QT
measurement in digital ECGs acquired at a lower
sampling rate is not clear. We, therefore, studied QT
interval measurements in Holter ECGs recorded at 180
and 1000 s/s with and without resampling.
2. Material and methods
Two 12-lead Holter recorders (Model H12+, Mortara
Instrument, Milwaukee, WI) were connected using dual-
snap electrodes and 5 hour recordings acquired
simultaneously from 16 healthy volunteers. One Holter
device recorded the digital ECG signal at a sampling
frequency of 180 s/s and the other at 1000 s/s, with a 16-
bit amplitude resolution (2.5 µV). 10-second ECG
snapshots were extracted from the simultaneous Holter
recordings at 30 identical time-points from each subject.
Snapshots were extracted at heart rates between 50-60
bpm, 61-70 bpm, 71-80 bpm, 81-90 bpm, 91-100 bpm
and ≥101 bpm. Thus, 480 ECGs at a sampling rate of 180
s/s and 480 simultaneous ECGs at a sampling rate of
1000 s/s from 16 subjects were obtained.
ECG resampling
ECGs recorded at 180 s/s were up-sampled to 500 s/s
and 1000 s/s and those recorded at 1000 s/s were down-
sampled to 500 s/s and 180 s/s using commercially
available software (Antares version 2.2.3, AMPS LLC,
New York)
2
and converted to HL7 compliant XML files.
Thus, six sets of ECGs were created 180 s/s without
resampling; 180 s/s resampled to 500 s/s, 180 s/s
resampled to 1000 s/s and 1000 s/s without resampling,
1000 s/s resampled to 500 s/s and 1000 s/s resampled to
180 s/s. ECGs recorded at 180 s/s were also up-sampled
to 1000 s/s using another software application (H-Scribe,
Version 4.3, Mortara Inc), thereby creating seven sets.
ISSN 0276−6574 761 Computing in Cardiology 2010;37:761−764.
762
Table 1. Comparison of QT intervals measured by the CalECG algorithm in 12-lead digital Holter ECGs recorded at 180
s/s resampled to 500 and 1000 s/s compared to the ‘gold standard’ i.e. ECGs recorded at 1000 s/s
ECG
interval
Comparison between ECG sets
Mean
Standard
Deviation
Min
Diff
Max
Diff
LOA
P value
QT
180 s/s vs 1000 s/s
5.0
6.3
-35.2
23.1
-7.6 to 17.7
<0.0001
180 s/s@500s/s vs 1000s/s
2.1
5.8
-35
25
-9.5 to 13.8
<0.0001
180 s/s@1000s/s vs 1000s/s
2.6
6.2
-37
38
-9.8 to 15.0
<0.0001
QRS
180 s/s vs 1000 s/s
4
5.2
-15.7
33.7
-6.4 to 14.3
<0.0001
180 s/s @ 500 s/s vs 1000 s/s
2.1
4.2
-16
17
-6.3 to 10.5
<0.0001
180 s/s @ 1000 s/s vs 1000 s/s
2.2
4.6
-16
20
-7 to 11.3
<0.0001
JT
180 s/s vs 1000 s/s
1.1
5.1
-21.8
17.9
-9.1 to 11.3
<0.0001
180 s/s @ 500 s/s vs 1000 s/s
0
4.7
-22
30
-9.3 to 9.4
0.88
180 s/s @ 1000 s/s vs 1000 s/s
0.4
4.5
-21
28
-8.7 to 9.5
0.04
All values in milliseconds. Min: Minimum, Max: Maximum
Table 2. Comparison of QT intervals measured by the CalECG algorithm in 12-lead digital Holter ECGs recorded at 180
s/s and 1000 s/s and resampled to identical sampling rates of 1000 s/s, 500 s/s and 180 s/s
Comparison between ECG sets
Mean
Standard
Deviation
Min
Max
LOA
Range
of LOA
P value
180 s/s@1000s/s vs 1000s/s
2.6
6.2
-37
38
-9.8 to 15.0
24.8
<0.0001
180 s/s @ 500 s/s vs 1000 s/s@ 500 s/s
1.8
5.5
-16
32
-9.3 to 12.9
22.1
<0.0001
180 s/s vs 1000 s/s @180 s/s
0.4
5.9
-22.2
22.2
-11.3 to 12.2
23.5
0.10
Table 3. Comparison of QT interval measurements re-sampled to the common sampling rate of 500 s/s (by CalECG and
Uni-G) and 1000 s/s (by CalECG and Veritas)
ECG sampling rates
QT measurement
software used
Mean
Standard
Deviation
LOA
Range
of LOA
P value
180 s/s@500s/s vs 1000 s/s @ 500 s/s
CalECG
5.0
6.3
-7.6 to 17.7
25.3
<0.0001
Uni-G
2.1
5.8
-9.5 to 13.8
23.3
<0.0001
180 s/s @ 1000 s/s vs 1000 s/s
CalECG
4
5.2
-6.4 to 14.3
20.7
<0.0001
Veritas
2.1
4.2
-6.3 to 10.5
16.8
<0.0001
4. Discussion
Using the Holter ECGs acquired at 1000 s/s as the
gold standard, we found that the mean automated QT
interval measurement in corresponding ECGs recorded at
180 s/s was greater than the gold standard by 5.0 ms.
This difference decreased to 2.1 ms on up-sampling the
180 s/s ECGs to 500 s/s and to 2.6 ms at 1000 s/s. In
order to identify why QT measurements are longer in
ECGs recorded at 180 s/s than in corresponding ECGs
acquired at 1000 s/s, we compared the QRS duration and
JT interval in the same sets of ECGs. While the JT
intervals were comparable in ECGs recorded at 180 s/s
and 1000 s/s, the QRS duration was greater in the 180 s/s
ECGs by a mean of 4 ms, suggesting that the difference
in the QT intervals was almost entirely accounted for by
the QRS duration and not the JT interval.
Previous studies have shown that sampling rate
significantly influences the amplitude of high-frequency
components of the ECG waveform; the QRS amplitude is
lower in ECGs recorded at lower sampling rates.
6,7
The
present study revealed that a lower sampling rate also
affects the duration of high frequency components of the
ECG waveform like the QRS complex; the QRS duration
in ECGs acquired at 180 s/s was 5 ms longer than that in
ECGs acquired at 1000 s/s. One possible explanation for
this is that automated algorithms can place fiducial points
only on sampling points (Figure 2).
3
Since the QRS onset
is identified as the last data point on the PR interval and
QRS offset as the first data point on the ST segment,
these will be further apart on ECGs recorded at 180 s/s
(Figure 3).
ECGs acquired at different sampling rates may also
have to be re-sampled to a common rate because
automated algorithms are programmed to perform at a
specific sampling rate. The Uni-G algorithm measures
QT interval only at 500 s/s while the Veritas algorithm
measures QT intervals only at 1000 s/s. We found that
the difference between QT intervals in ECGs recorded at
180 s/s and 1000 s/s decreased when both sets were
resampled to the same sampling rate; the difference
decreased progressively from 1000 s/s to 500 s/s to 180
s/s. Again, this is possibly because fiducial points are
placed only on sample points.
3
Therefore, agreement
between the two sets of ECGs is apparently best at 180
s/s where the sample points are 5.6 ms apart rather than
when sample points are 1 or 2 ms apart at 1000s/s or
500s/s respectively. However, it must be remembered
that ECGs at 180 s/s have a longer measured QT interval
than the same ECG recorded at 1000 s/s. Therefore,
763
764
Article
To study the differences in QTc interval on ECG in response to a single oral dose of rac-sotalol in men and women. Continuous 12-lead ECGs were recorded in 28 men and 11 women on a separate baseline day and following a single oral dose of 160 mg on the following day. ECGs were extracted at prespecified timepoints and upsampled to 1000 Hz and analyzed manually in a central ECG laboratory on the superimposed median beat. Concentration-QTc analyses were performed using a linear mixed-effects model. Rac-sotalol produced a significant reduction in heart rate in men and in women. An individual correction method (QTcI) most effectively removed the heart rate dependency of the QTc interval. Mean QTcI was 10 to 15 ms longer in women at all timepoints on the baseline day. Rac-sotalol significantly prolonged QTcI in both sexes; the largest mean change in QTcI (ΔQTcI) was greater in females (68 ms (95% confidence interval (CI): 59 ms to 76 ms) versus 27 ms (95% CI: 22 to 32 ms) in males). Peak rac-sotalol plasma concentration was higher in women than in men (mean Cmax 1.8 μg/ml (range 1.1 to 2.8) vs. 1.4 μg/ml (range 0.9 to 1.9); p=0.0009). The slope of the concentration - ΔQTcI relationship too was steeper in women (30 ms per μg/mL versus 23 ms per μg/mL in men; p= 0.0135). The study provides evidence for a greater intrinsic sensitivity to rac-sotalol in women than in men for drug-induced delay in cardiac repolarization.
Article
Full-text available
Well-specified recommendations have yet to be established on how electrocardiogram (ECG) interval measurement should be performed by digital on-screen caliper systems to assess drug-induced effect on cardiac repolarization in pharmaceutical clinical trials with adequate precision and reproducibility. Since 1997, the industry has followed the European Committee for Proprietary Medicinal Products Points to Consider by using fully manual measurement of 3 consecutive sinus rhythm PQRST complexes in 1 lead only (typically limb lead II). More recently, semiautomatic measurement performed on representative (median) beats and based on the global leads has been considered. The International Conference on Harmonization E14 guidance (June 2005) advocates development of quality standards for centralized ECG interval measurement and allows all methods "whether or not assisted by computer" but includes no recommendations on how to perform the measurement. We provide an overview of the currently available methods for digital ECG interval measurement and the implications of between-method differences on quality of ECG interval measurements. We applied 4 methods most commonly used to assess QT prolongation (applied on 3 raw beats in limb lead II or by global measurement on 1 or 12 superimposed representative beats). QT, QTc Fridericia, and RR interval durations were measured on resting 12-lead digital ECGs obtained in 26 healthy volunteers predose and at 1, 2, and 3 hours after dosing with a single 160 mg oral dose of sotalol. Absolute interval durations and changes from baseline were compared between the 4 measurement methods. A better understanding of the implications from different measurement methodologies will facilitate more informed choice of the appropriate method for ECG interval measurement on clinical trials.
Article
Concern for drug-induced QT prolongation has caused significant investment in QT measurement to safety-test new compounds. Manual methods are expensive and time-consuming. Reliable automatic methods would be highly desirable. Twelve-lead Holter recordings were annotated beat-to-beat by an automatic algorithm for global QRS onset and T offset. T offset was established from the time of peak T downslope plus a rate-dependent offset, analogous to the "tangent method," wherein T offset is determined by extrapolating the T downslope to an intersection with the baseline. Variances of the beat-to-beat QT measurements were in the range 2.5-3.4 ms over three distinct databases, including a large heart failure database. Application to a moxifloxacin/placebo control database of 29 subjects showed excellent results.
Article
Continuous 12-lead ECG monitoring (Holter) in early-phase pharmaceutical studies is today widely used as an ideal platform to extract discrete ECGs for analysis. The extraction process is typically performed manually by trained readers using commercial Holter processing systems. Antares, a novel method for automatic 12-lead extraction from continuous Holter recordings applying minimal noise criteria and heart-rate stability conditions is presented. A set of 12-lead Holter recordings from healthy subjects administered with sotalol is used to compare ECG extractions at fixed time points with ECG extractions generated by Antares optimizing noise and heart rate inside 5 minute windows centered around each expected time point of interest. Global, low- and high-frequency noise content of extracted ECGs was significantly reduced via optimized approach by Antares. Heart rate was also slightly reduced (from 69 +/- 13 to 64 +/- 13 bpm, P < 0.05). Similarly, the corrected QT interval from optimized extractions was significantly reduced (QTcB from 414 +/- 32 to 402 +/- 30 ms, P < 0.05). Using only baseline data, and after adjusting for intersubject variability, the standard deviation (SD) of QT intervals was highly reduced with optimized extraction (SD of QTcF from 11 +/- 8 to 7 +/- 2 ms, P < 0.05). Extraction of discrete 12-lead ECG strips from continuous Holter generates less noisy and more stable ECGs leading to more robust QTc data, thereby potentially facilitating the assessment of ECG effects on clinical trials.
Article
The details of digital recording and computer processing of a 12-lead electrocardiogram (ECG) remain a source of confusion for many health care professionals. A better understanding of the design and performance tradeoffs inherent in the electrocardiograph design might lead to better quality in ECG recording and better interpretation in ECG reading. This paper serves as a tutorial from an engineering point of view to those who are new to the field of ECG and to those clinicians who want to gain a better understanding of the engineering tradeoffs involved. The problem arises when the benefit of various electrocardiograph features is widely understood while the cost or the tradeoffs are not equally well understood. An electrocardiograph is divided into 2 main components, the patient module for ECG signal acquisition and the remainder for ECG processing which holds the main processor, fast printer, and display. The low-level ECG signal from the body is amplified and converted to a digital signal for further computer processing. The Electrocardiogram is processed for display by user selectable filters to reduce various artifacts. A high-pass filter is used to attenuate the very low frequency baseline sway or wander. A low-pass filter attenuates the high-frequency muscle artifact and a notch filter attenuates interference from alternating current power. Although the target artifact is reduced in each case, the ECG signal is also distorted slightly by the applied filter. The low-pass filter attenuates high-frequency components of the ECG such as sharp R waves and a high-pass filter can cause ST segment distortion for instance. Good skin preparation and electrode placement reduce artifacts to eliminate the need for common usage of these filters.